# A Study of HTD1801 in Healthy Subjects

> **NCT03099603** · PHASE1 · COMPLETED · sponsor: **HighTide Biopharma Pty Ltd** · enrollment: 32 (actual)

## Conditions studied

- Primary Sclerosing Cholangitis

## Interventions

- **DRUG:** HTD1801

## Key facts

- **NCT ID:** NCT03099603
- **Lead sponsor:** HighTide Biopharma Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-24
- **Primary completion:** 2017-07-11
- **Final completion:** 2017-10-03
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2020-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03099603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03099603, "A Study of HTD1801 in Healthy Subjects". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03099603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*